Schedule 13D
Item 1. Security and Issuer
This Schedule 13D (this “Schedule 13D”) relates to shares of common stock, par value $0.10 per share (the “Common Stock”), of Atrion Corporation, a Delaware corporation (“Issuer”). Issuer’s principal executive offices are located at One Allentown Parkway, Allen, TX 75002.
Item 2. Identity and Background
This Schedule 13D is being filed by Nordson Corporation, an Ohio corporation (“Nordson”), with a principal business address of 28601 Clemens Road Westlake, OH 44145 (the “Reporting Person”).
The principal business of Nordson is engineering, manufacturing and marketing differentiated products and systems used for precision dispensing, applying and controlling of adhesives, coatings, polymers, sealants, biomaterials, and other fluids, to test and inspect for quality, and to treat and cure surfaces and various medical products such as catheters, cannulas, medical balloons and medical tubing. Alpha Medical Merger Sub, Inc. (“Merger Sub”) is a wholly owned subsidiary of Nordson and was recently incorporated for the purpose of the Merger (as defined below) upon the terms and subject to the conditions set forth in the Merger Agreement (as defined below).
Set forth on Annex A to this Schedule 13D, and incorporated herein by reference, is a list of the executive officers and directors of the Reporting Person (the “Scheduled Persons”) that contains the following information with respect to each such person: (a) name, (b) business address, (c) present principal occupation or employment (including the name and the principal business address, if other than Nordson, of any corporation or other organization in which such employment is conducted), and (d) citizenship. Except as set forth otherwise on Annex A, each person identified on Annex A is a citizen of the United States.
During the last five years, neither the Reporting Person, nor, to the best of their knowledge, any of the Scheduled Persons, has been (i) convicted in any criminal proceeding (excluding traffic violations or similar misdemeanors) or (ii) a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.
Item 3. Source and Amount of Funds or other Consideration
Items 4 and 5 are incorporated by reference in this Item 3 as if fully set forth herein.
Pursuant to, and subject to the terms and conditions contained in, the Voting Agreements described in Item 4 of this statement, the Reporting Person may be deemed to have acquired beneficial ownership of the Subject Shares (as defined below) by virtue of the execution of the Voting Agreements (as defined in Item 4 below) by Nordson and with certain shareholders named on Annex B hereto (each, a “Voting Party” and together the “Voting Parties”).
The shares of Common Stock beneficially owned by the Voting Parties have not been purchased by the Reporting Person, and thus no payments were made by or on behalf of the Reporting Person in connection with the execution of the Merger Agreement (as defined in Item 4 below) or the execution of the Voting Agreements. The Voting Parties will receive the same consideration per share of Common Stock as other shareholders receive pursuant to the terms of the Merger Agreement.
Item 4. Purpose of Transaction
Items 3 and 5 are incorporated by reference in this Item 4 as if fully set forth herein.
Merger Agreement
On May 28, 2024, Nordson, Issuer and Merger Sub entered into an Agreement and Plan of Merger (the “Merger Agreement”), pursuant to which, among other things, on the terms and subject to the conditions set forth therein, Merger Sub will merge with and into Issuer (the “Merger”), with Issuer surviving the Merger as a wholly owned subsidiary of Nordson.